NAV
$35.95
AUM
$129.1M
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.00
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +36.50% | +5.16% | +27.86% | +59.51% | - | - |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | 2330.TW | Taiwan Semiconductor Manufacturing Co Ltd | 11.61% |
| 2 | 005930.KS | Samsung Electronics Co Ltd | 8.65% |
| 3 | 000660.KS | SK Hynix Inc | 8.33% |
| 4 | ASML.AS | ASML Holding NV | 4.35% |
| 5 | 0700.HK | Tencent Holdings Ltd | 3.19% |
| 6 | NOVN.SW | Novartis AG Registered Shares | 2.34% |
| 7 | ROP.SW | Roche Holding AG Ordinary Shares new | 2.18% |
| 8 | 7203.T | Toyota Motor Corp | 2.17% |
| 9 | 9984.T | SoftBank Group Corp | 2.15% |
| 10 | AZN.L | AstraZeneca PLC | 2.10% |
The index is a rules-based full market capitalization-weighted index that consists of companies from the Nasdaq Global Ex United States Large Mid Cap Index with the most valuable patent portfolios. The fund will generally use a “replication” strategy to achieve its investment objective, meaning it will invest in all of the component securities of the index. The fund is non-diversified.
Inception Date: 2024-09-16